Denis Azhgirevich

Denis Azhgirevich is an experienced M&A advisory professional currently serving as the Managing Partner M&A at Nexus Capital.1 He specializes in mergers and acquisitions with a primary focus on the Pharma, FMCG, Packaging, and IT sectors.1

Professional Background

Azhgirevich has a strong presence in the pharmaceutical and M&A industries. He regularly shares insights and updates about significant deals and industry trends. For instance, he reported on Eurofarma Laboratórios S.A.'s acquisition of Genfar S.A. from Sanofi for approximately 300 million.3

Contributions and Expertise

As part of his role, Azhgirevich publishes a Pharma M&A Newsletter, providing essential news and analysis in the Russian pharmaceutical industry. He has released editions covering various months, including September and November 2021.45 These newsletters likely offer valuable insights into the current state and future trends of pharmaceutical mergers and acquisitions in Russia.

Career Progression

Azhgirevich's LinkedIn profile indicates that he started his position as Managing Partner at Nexus Capital relatively recently. He has expressed enthusiasm about this new role in his professional journey.26

Through his work and online presence, Denis Azhgirevich demonstrates a deep understanding of the M&A landscape, particularly in the pharmaceutical sector, and continues to be an active voice in the industry.